1.76
1.73%
0.03
Handel nachbörslich:
1.79
0.03
+1.70%
Finanzdaten der Essa Pharma Inc-Aktie (EPIX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Operating Expenses
|
38.17%
10.49
|
7.5946 | 7.1497 | 8.9121 | 8.2135 |
Income/Loss From Continuing Operations Before Tax |
50.72%
-8.9895
|
-5.9643 | -5.4813 | -7.2989 | -7.0586 |
Income/Loss From Continuing Operations After Tax |
50.72%
-8.9895
|
-5.9643 | -5.4813 | -7.2989 | -7.0602 |
Net Income/Loss
|
50.72%
-8.9895
|
-5.9643 | -5.4813 | -7.2989 | -7.0602 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.24%
44.24
|
44.13 | 0.00362 | 44.09 | 44.09 |
Diluted Average Shares |
0.24%
44.24
|
44.13 | 0.00362 | 44.09 | 44.09 |
Basic Earnings Per Share |
42.86%
-0.20
|
-0.14 | -0.12 | -0.17 | -0.16 |
Diluted Earnings Per Share |
42.86%
-0.20
|
-0.14 | -0.12 | -0.17 | -0.16 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):